Accession Number: | 0001209191-21-063676 |
Date: | 2021-11-05 |
Issuer: | MYOVANT SCIENCES LTD. (MYOV) |
Original Submission Date: |
GULFO ADELE M.
C/O MYOVANT SCIENCES INC.
2000 SIERRA POINT PARKWAY, 9TH FLOOR
BRISBANE, CA 94005
Title of Security | Transaction Date | 2a. Deemed Execution Date | Transaction Code | Shares | Acquired or Disposed | Price per share | 5. Amount of Securities Beneficially Owned Following Reported Transaction | 6. Ownership Form Direct or Indirect | Nature of Indirect Ownership |
---|
Title of Derivative Security | Conversion or Exercise Price of Derivative Security | Transaction Date | Deemed Execution Date | Transaction Code | Number of Derivative Securities Acquired (A) or Disposed of (D) | Date Exercisable | Expiration Date | Title and Amount of Securities Underlying Derivative Security | Price of Derivative Security | Number of derivative Securities Beneficially Owned Following Reported Transaction(s) | Ownership Form: Direct (D) or Indirect (I) | Nature of Indirect Beneficial Ownership |
---|---|---|---|---|---|---|---|---|---|---|---|---|
STOCK OPTION (RIGHT TO BUY) | 22.71 | 2021-11-05 | deemed execution date | A | 21,096 (a) | 2031-11-04 | common shares 21,096 | $22.71 | 21,096 | direct |
ID | footnote |
---|---|
f1 | 100% of the shares underlying the option vest and become exercisable on the earlier of (a) november 5, 2022, and (b) the date that is one day prior to the issuer's 2022 annual general meeting of shareholders, subject to the reporting person providing continuous service to the issuer on such date. |